Catherine Nalpas
2PUBLICATIONS
6CO-AUTHORS

Get your video featured.

Get your video featured.
Publications (2)
Sort by Publication Date:
|Mar 04, 2026
Efficacy and safety of rimegepant 75 mg orally disintegrating tablet for the acute treatment of chronic rhinosinusitis in adults: Results from a multicenter, randomized, placebo-controlled, phase 2/3 trial.Daniel Franjic, Robert J Fountaine, Catherine Nalpas
|Nov 19, 2025
Rimegepant for acute treatment of migraine in triptan-unsuitable adults: A randomized, double-blind, placebo-controlled phase 4 trial.Messoud Ashina, Peter McAllister, Charly Gaul
Pageof 1

